Key result
Ticagrelor raises serum uric acid post-PCI but does not increase high platelet reactivity in STEMI.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Ticagrelor use is related to a significant increase in the serum uric acid levels at 30 days post-PCI in this patient cohort. The variations in the uric acid levels do not increase the percentage of high platelet reactivity in STEMI patients treated with ticagrelor or clopidogrel.
No takes yet. Share an insight, caveat, or question.
Song et al. (2021) studied this question. Ticagrelor significantly increased serum uric acid at 30 days post-PCI, but these variations did not increase high platelet reactivity in STEMI patients.
Synapse has enriched 6 related papers. Consider them for comparative context: